NewAmsterdam Pharma (NAMS) Earnings Date & Reports

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NAMS is expected to report earnings to fall 4.83% to -49 cents per share on November 11

NewAmsterdam Pharma NAMS Stock Earnings Reports

Q3'26

Est.

$-0.49

Q2'26

Missed

by $0.04

Q1'26

Beat

by $0.09

Q4'25

Missed

by $0.23

Q3'25

Missed

by $0.21

The last earnings report on August 05 showed earnings per share of -51 cents, missing the estimate of -48 cents. With 319.58K shares outstanding, the current market capitalization sits at 2.82B.

View a ticker or compare two or three

NAMS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for NAMS